Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 2652-2660, November 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chae, C.-B.
Right arrow Articles by Piantadosi, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chae, C.-B.
Right arrow Articles by Piantadosi, C.

Inhibition of Thymidine Phosphorylation and DNA and Histone Synthesis in Ehrlich Ascites Carcinoma1

Chi-Bom Chae, Ann Williams, Harvey Krasny, J. Logan Irvin and Claude Piantadosi

Departments of Biochemistry and Medicinal Chemistry, University of North Carolina, Chapel Hill, North Carolina 27514

The time course of phosphorylation of thymidine and the effects of various inhibitors on the phosphorylation of thymidine and on DNA synthesis in Ehrlich ascites carcinoma cells in vitro were studied with a double-isotope labeling method. Hydroxyurea, mitomycin C, cycloheximide, puromycin, 1-ß-D-arabinofuranosylcytosine, 5-fluoroorotic aldehyde, and the thiosemicarbazones of 2-phthalimido aliphatic aldehydes inhibit incorporation of thymidine-2-14C into DNA and produce an accumulation of label in thymidine 5'-triphosphate in Ehrlich ascites carcinoma cells in vitro.

A concentration (0.01 mM) of 1-ß-D-arabinofuranosyl-cytosine that inhibits incorporation of thymidine into DNA by 75% also depresses incorporation of labeled glycine into slightly lysine-rich histones (70%), lysine-rich histones (30%), and arginine-rich histones (20%); incorporation of labeled glycine into total cytoplasmic proteins is not inhibited by this concentration of 1-ß-D-arabinofuranosylcytosine in short-term experiments.

1 Aided by American Cancer Society Grants E-24J and In-15-?? and NIH Grants GM-08318-08 and CA-10729.

Received 11/13/69. Accepted 7/ 2/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.